The application of deep learning in the detection of Synthetic Aperture Radar (SAR) targets has been primarily limited to large objects such as ships and airplanes, with much less popularity in detecting SAR vehicles. The complexities of SAR imaging make it difficult to distinguish small vehicles from the background clutter, creating a barrier to data interpretation and the development of Automatic Target Recognition (ATR) in SAR vehicles. The scarcity of datasets has inhibited progress in SAR vehicle detection in the data-driven era. To address this, we introduce a new synthetic dataset called Mix MSTAR, which mixes target chips and clutter backgrounds with original radar data at the pixel level. Mix MSTAR contains 5,392 objects of 20 fine-grained categories in 100 high-resolution images, predominantly 1478x1784 pixels. The dataset includes various landscapes such as woods, grasslands, urban buildings, lakes, and tightly arranged vehicles, each labeled with Oriented Bounding Box (OBB). Notably, Mix MSTAR presents fine-grained object detection challenges by using the Extended Operating Condition (EOC) as a basis for dividing the dataset. Furthermore, we evaluate 9 benchmark rotated detectors on Mix MSTAR and demonstrate the fidelity and effectiveness of the synthetic dataset. To the best of our knowledge, Mix MSTAR represents the first public multi-class SAR vehicle dataset designed for rotated object detection in large-scale scenes with complex background. Mix MSTAR is available at: https://github.com/TheGreatTreatsby/Mix-MSTAR-mmrotate.

There is a current pandemic of a new type of coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The number of confirmed infected cases has been rapidly increasing. This paper analyzes the characteristics of SARS-CoV-2 in comparison with Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and influenza. COVID-19 is similar to the diseases caused by SARS-CoV and MERS-CoV virologically and etiologically, but closer to influenza in epidemiology and virulence. The comparison provides a new perspective for the future of the disease control, and offers some ideas in the prevention and control management strategy. The large number of infectious people from the origin, and the highly infectious and occult nature have been two major problems, making the virus difficult to eradicate. We thus need to contemplate the possibility of long-term co-existence with COVID-19.

(1) Background: Heart failure (HF) is the final stage of multiple cardiac diseases, which has now become a severe public health problem worldwide. β-Adrenergic receptor (β-AR) overactivation is a major pathological factor associated with multiple cardiac diseases and mediates cardiac fibrosis and inflammation. Previous study has demonstrated that Bruton's tyrosine kinase (BTK) mediated cardiac fibrosis by TGF-β related signal pathways, indicating that BTK was a potential drug target for cardiac fibrosis. Zanubrutinib, a second-generation BTK inhibitor, has shown anti-fibrosis effects in previous research. However, it is unclear whether Zanubrutinib can alleviate cardiac fibrosis induced by β-AR overactivation;(2) Methods: In vivo: Male C57BL/6J mice were treated with or without the β-AR agonist isoproterenol (ISO) to establish cardiac fibrosis animal model. Here, results showed that BTK inhibitor Zanubrutinib (ZB) had a great effect on cardiac fibrosis and inflammation induced by β-AR. In vitro: Results showed that ZB alleviated β-AR-induced cardiac fibroblast activation and macrophage proinflammatory cytokine production. Further mechanism studies demonstrated that ZB inhibited β-AR-induced cardiac fibrosis and inflammation by BTK、STAT3、NF-κB and PI3K/Akt signal pathways both in vivo and in vitro; (4) Conclusions: our research provides evidence that ZB ameliorates β-AR-induced cardiac fibrosis and inflammation.